M.J. Mackie

1.4k total citations · 1 hit paper
39 papers, 1.1k citations indexed

About

M.J. Mackie is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, M.J. Mackie has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 9 papers in Genetics and 8 papers in Pathology and Forensic Medicine. Recurrent topics in M.J. Mackie's work include Lymphoma Diagnosis and Treatment (8 papers), Acute Myeloid Leukemia Research (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). M.J. Mackie is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Acute Myeloid Leukemia Research (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). M.J. Mackie collaborates with scholars based in United Kingdom, Australia and South Africa. M.J. Mackie's co-authors include B. A. McVerry, Martin J. Auger, M Fitchett, Gösta Gahrton, Erkki Elonen, David Oscier, Sakari Knuutila, Gian Luigi Castoldi, G. Stockdill and A. C. Parker and has published in prestigious journals such as New England Journal of Medicine, Cancer and Gut.

In The Last Decade

M.J. Mackie

38 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic Subgroups in B-Cell Chronic Lymphocytic Leukemia Defined by Specific Chromosomal Abnormalities

1990 502 citations Gunnar Juliusson, David Oscier et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by M.J. Mackie

Since Specialization

Citations

This map shows the geographic impact of M.J. Mackie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.J. Mackie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.J. Mackie more than expected).

Fields of papers citing papers by M.J. Mackie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.J. Mackie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.J. Mackie. The network helps show where M.J. Mackie may publish in the future.

Co-authorship network of co-authors of M.J. Mackie

This figure shows the co-authorship network connecting the top 25 collaborators of M.J. Mackie. A scholar is included among the top collaborators of M.J. Mackie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.J. Mackie. M.J. Mackie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	What would have happened anyway? Population data source considerations when estimating background incident rates of adverse events following immunisation to inform vaccine safety 2024 ·Vaccine ·Hazel J Clothier, (unknown), (unknown), M.J. Mackie, Christopher Pearce, Jim Buttery	3
2	The development of targeted chemotherapy for CNS lymphoma?a pilot study of the IDARAM regimen 2004 ·Cancer Chemotherapy and Pharmacology ·Paul Moreton, Gareth J. Morgan, D. Gilson, Graeme Smith, B. A. McVerry, J. M. Davies, M.J. Mackie, (unknown), (unknown), M R Howard, L. A. Parapia, (unknown), J. A. Child	14
3	A multicentre, open, non‐comparative phase II study of a combination of fludarabine phosphate, cytarabine and granulocyte colony‐stimulating factor in relapsed and refractory acute myeloid leukaemia and de novo refractory anaemia with excess of blasts in transformation 2001 ·British Journal of Haematology ·Graham Jackson, P R Taylor, Graeme Smith, R. E. Marcus, Alastair G. Smith, Patrick Chu, Timothy J. Littlewood, Andrew Duncombe, Michael Hutchinson, Atul Mehta, S.A. Johnson, Peter Carey, M.J. Mackie, Peter Ganly, Gillian Turner, Miriam Deane, Steve Schey, Jonathan Brookes, Susan M. Tollerfield, Marcia Wilson	99
4	Rapid detection of BCR/ABL and PML/RARA using fluorescence in situ hybridization in cytospin preparations 2000 ·Clinical & Laboratory Haematology ·(unknown), A.M. Ford, M.J. Mackie, Peter Johnson	1
5	8;21 translocation with duplication of the der(21) in a patient with myelomonocytic leukemia 1991 ·Cancer Genetics and Cytogenetics ·Martin J. Auger, (unknown), M.J. Mackie	6
6	Discrete subpopulations, defined by CD45 isoforms, coexist within the leukaemic cells of B-chronic lymphocytic leukaemia patients 1991 ·Leukemia Research ·Alun Maddy, A. Bruce Lyons, (unknown), Helen R. Taylor, Andrew Sanderson, M.J. Mackie	3
7	Prognostic Subgroups in B-Cell Chronic Lymphocytic Leukemia Defined by Specific Chromosomal Abnormalities breakdown → 1990 ·New England Journal of Medicine ·Gunnar Juliusson, David Oscier, M Fitchett, (unknown), G. Stockdill, M.J. Mackie, A. C. Parker, Gian Luigi Castoldi, (unknown), Sakari Knuutila, Erkki Elonen, Gösta Gahrton	502
8	An immunocytochemical study of lymphocyte and macrophage populations in the bone marrow of patients with non‐Hodgkin's lymphoma 1988 ·The Journal of Pathology ·(unknown), Steven R. Smith, M.J. Mackie	5
9	Haemostasis in Malignant Disease 1988 ·Journal of the Royal College of Physicians of London ·Martin J. Auger, M.J. Mackie	7
10	A Quantitative Study of Monocyte Procoagulant Activity in Acute Monoblastic and Chronic Myelomonocytic Leukaemias 1987 ·Acta Haematologica ·Martin J. Auger, M.J. Mackie	6
11	Monocyte procoagulant activity in breast cancer 1987 ·Thrombosis Research ·Martin J. Auger, M.J. Mackie	21
12	Elevated Fibrinopeptide A Levels in Patients with Clinically Localised Breast Carcinoma 1987 ·Pathophysiology of Haemostasis and Thrombosis ·Martin J. Auger, M J Galloway, Sam Leinster, B. A. McVerry, M.J. Mackie	7
13	Diminished Extractable Spectrin in the Erythrocytes of a Patient with ‘Sporadic’ Hereditary Spherocytosis 1986 ·Acta Haematologica ·(unknown), M.J. Mackie, (unknown)	3
14	Fetal and maternal uteroplacental leucocytes in aplastic anaemia. Case report 1986 ·BJOG An International Journal of Obstetrics & Gynaecology ·Ruth Spearing, M.J. Mackie, Janet M. Risk, Peter Johnson, Judith N. Bulmer	2
15	Marrow involvement with T cell lymphoma initially presenting as abnormal myelopoiesis. 1986 ·Journal of Clinical Pathology ·Martin J. Auger, J R Nash, M.J. Mackie	21
16	Fibronectin C in acute leukaemia 1984 ·British Journal of Haematology ·J. T. Reilly, M J Galloway, M.J. Mackie, B. A. McVerry	3
17	Circulating plasmin-antiplasmin complexes in acute leukaemia 1983 ·Clinical & Laboratory Haematology ·M J Galloway, M.J. Mackie, B. A. McVerry	2
18	Chronic Inflammatory Bowel Disease, Deep-Venous Thrombosis and Antithrombin Activity 1983 ·Acta Haematologica ·(unknown), M.J. Mackie, B. A. McVerry, (unknown), (unknown), (unknown)	26
19	ORAL ANTICOAGULANTS IN ARTERIAL DISEASE 1978 ·British Medical Bulletin ·M.J. Mackie, A S Douglas	8
20	Familial Thrombosis Due to Antithrombin III Deficiency: An Extensive Family Study 1977 ·Thrombosis and Haemostasis ·Bruce Bennett, M.J. Mackie, (unknown)	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact